A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2015; you can also visit the original URL.
The file type is
A multicenter, open-label study of the efficacy and safety of telmisartan in mild to moderate hypertensive patients
Arquivos Brasileiros de Cardiologia
Objective -To evaluate the efficacy and tolerability of telmisartan, given once a day to patients with mild to moderate hypertension, as well as to assess the 24-hour blood pressure profile with ABPM. Methods -Initially, 163 patients over 18 were selected, regardless of sex, with blood pressure levels >140/90mmHg at visit 1, which was confirmed at visit 2. One hundred thirty-four patients completed the study. After a 4-week placebo run-in phase, telmisartan 40mg/daily was given for 6 weeks. Indoi:10.1590/s0066-782x2002001300002 pmid:12426643 fatcat:igkaflepdbaf3licemo352zs4a